Labcorp (LH) said Monday that Geneoscopy's at-home test for colorectal cancer screening ColoSense is available in the US.
The test is being offered via a commercial collaboration with Geneoscopy, Labcorp said, adding that it expands its line of colorectal cancer screening products.
The test is covered for eligible Medicare and Medicare Advantage beneficiaries, and commercial coverage is also available, Labcorp said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments